Bausch + Lomb Corporation (BLCO)

USD 18.24

(-3.24%)

Net Debt Summary of Bausch + Lomb Corporation

  • Bausch + Lomb Corporation's latest annual net debt in 2023 was 4.23 Billion USD , up 103.22% from previous year.
  • Bausch + Lomb Corporation's latest quarterly net debt in 2024 Q3 was 4.3 Billion USD , down -0.69% from previous quarter.
  • Bausch + Lomb Corporation reported annual net debt of 2.08 Billion USD in 2022, up 3458.06% from previous year.
  • Bausch + Lomb Corporation reported annual net debt of -62 Million USD in 2021, up 54.74% from previous year.
  • Bausch + Lomb Corporation reported quarterly net debt of 4.33 Billion USD for 2024 Q2, up 1.67% from previous quarter.
  • Bausch + Lomb Corporation reported quarterly net debt of 4.25 Billion USD for 2024 Q1, up 0.66% from previous quarter.

Annual Net Debt Chart of Bausch + Lomb Corporation (2023 - 2019)

Historical Annual Net Debt of Bausch + Lomb Corporation (2023 - 2019)

Year Net Debt Net Debt Growth
2023 4.23 Billion USD 103.22%
2022 2.08 Billion USD 3458.06%
2021 -62 Million USD 54.74%
2020 -137 Million USD -38.38%
2019 -99 Million USD 0.0%

Peer Net Debt Comparison of Bausch + Lomb Corporation

Name Net Debt Net Debt Difference
Alcon Inc. 4.04 Billion USD -4.479%
AptarGroup, Inc. 961.03 Million USD -340.256%
Baxter International Inc. 11.16 Billion USD 62.108%
Becton, Dickinson and Company 14.46 Billion USD 70.746%
Haemonetics Corporation 695.08 Million USD -508.703%
Envista Holdings Corp 713.6 Million USD -492.909%
ResMed Inc. 635.57 Million USD -565.697%
Teleflex Incorporated 1.7 Billion USD -148.368%
Warby Parker Inc. -42.43 Million USD 10070.073%
West Pharmaceutical Services, Inc. -544.9 Million USD 876.473%